As a mage, I just want to pursue the truth

Chapter 120 Patent Litigation
"The use of lithium metal cathode materials increases the energy density three times and the charging speed two times compared to batteries currently on the market."

This is actually a technology that Blue Star already has, but this technical route has only existed in the laboratory due to various difficulties that have not been overcome.

For example, lithium metal will expand due to charging and discharging, destroying the battery structure. Lithium metal and mainstream solid electrolyte materials are inferior and are likely to explode.

This lithium battery technology is not a mature technology of the Mage Alliance, but is a modification of the immature technology of Blue Star by Zheng Li.

The energy system of the Mage Alliance is not lithium batteries at all. They mainly rely on bioenergy and use a small amount of solid high-energy fuel.

The Alliance of Mages has a set of systematic theories on the construction of chemical materials, and their developments in computational chemistry extend as far as Blue Star.

Zheng Li calculated the structure of metallic lithium through the BioCloud and analyzed the metallic lithium positive electrode structure whose indicators best met the requirements of large-scale commercialization.

At the same time, a new graphene structural coating is introduced as an intermediate to prevent the lithium electrode from directly reacting with the solid electrolyte.

All the executives present were very shocked because they had never heard that Zheng Li knew anything about lithium batteries.

"Mr. Zheng, can this technology be implemented on a large scale? Or is it just a laboratory product?" Cheng Gang's question went straight to the point.

Laboratory products are a long way from commercialization.

The most important point for commercial products is cost.

The cost here includes not only manufacturing cost but also labor cost.

Like Ke Chuang Bio's first product, endorphin, the manufacturing cost is not high, but the labor cost is very high.

It takes at least half a year to train skilled workers for large-scale industrial production of endorphins to achieve a 95 percent yield rate.

After listening to this, Cheng Gang's first reaction was that the new structure of the lithium metal electrode should be arranged atom by atom to form a special structure.

This way it cannot be used commercially on a large scale.

The cost is too high.

Zheng Li: "The cost of laboratory manufacturing is about twice that of ordinary lithium battery positive electrode materials. If it is mass-produced industrially, the cost can be reduced."

"And I also plan to license the lithium metal cathode. We will not produce it directly."

The new energy industry chain has been booming in recent years, and the stock prices of companies upstream and downstream of the new energy industry chain have at least doubled.

22 is not as hot as 21, but the stock prices of new energy companies with good quality are still rising.

However, some companies that have built new production capacity but cannot find buyers for their new production capacity have seen their stock prices fluctuate sideways at high levels before falling all the way.

Because the industry's production capacity has expanded too much in 20 and 21, not all of the capacity can be digested. Those who have their production capacity expanded first will reap the benefits, while those who have their production capacity expanded later will be hit.

Once Kechuang Bio's lithium battery technology is announced, all companies producing positive electrode materials will be hit.

One or two limit downs are definitely not enough to stop the market from falling.

Cheng Gang was overjoyed. This was the biggest benefit for the company. Being able to increase the capacity of lithium batteries by three times meant that electric vehicles could truly compete with gasoline vehicles.

China has set a target of 2025 percent penetration by . Cheng Gang is certain that Scibio's lithium battery technology can double that rate.

Penetration rate refers to the market share of electric vehicles, and the target of 20% is actually not high at all.

The bill signed by American stipulates that the penetration rate of electric vehicles in the United States must reach 2030 percent by .

Cheng Gang breathed a sigh of relief as he finally found a way to make up for the huge losses he suffered from his investments in Abogen and Smibio.

Although executives of listed companies cannot engage in related-party transactions, if they want to purchase their own company's stock, they must issue an advance announcement.

Relatives of executives of listed companies are also not allowed to purchase shares illegally. For example, if a relative buys shares of Kechuang Biotechnology and then hears good news, the CSRC will investigate. However, this is only in theory. There are many ways to do it. For example, sign an agreement with a private equity company and let them purchase shares on your behalf, and share the profits after the purchase according to a certain proportion of the dividends.

There are many ways to do it.

And you don’t necessarily need to buy shares of Kechuang Biotechnology.

With such a major technological breakthrough in lithium batteries, companies related to new energy vehicles are bound to soar.

You just need to use leverage to buy stocks of new energy vehicle companies.

Cheng Gang was thinking about what to do.

Zheng Li continued in the video conference: "Lithium battery technology patents are only authorized to Chinese automakers."

"Foreign car companies and joint venture car companies are not considered at all. You need to think about the specific operation methods and external statements."

"Including our brain-computer interface VR, we can use brand-new battery technology."

“The licensing of lithium cathode technology to mobile phone manufacturers is not subject to this restriction.”

The executives present were puzzled, but no one asked questions in public.

Because of sensitive issues like this, the executives of Ke Chuang Bio all entrusted Li Miaomiao to ask Zheng Li, and then Li Miaomiao would decide whether to reveal to everyone the reasons why Zheng Li acted.

As for why this tradition has been formed, it may be because once a senior executive asked a question, Zheng Li moved on to the next agenda as if he didn't hear it.

It was really embarrassing to be ignored by the biggest boss in the executive meeting.

"As soon as possible, entrust a lawyer to register the patent, so that the news can be spread. I will send the samples back, and the samples can be given to domestic car manufacturers for testing."

"The specific structure and manufacturing method of the lithium metal positive electrode is known only to me, and there is no leakage of secrets."

After the meeting, all executives were excited. Influenced by this good news, it would be no problem for Kechuang Bio's stock price to double.

Super battery technology will be used in all new energy vehicles in China in the future. The unit price of the vehicle will be much more expensive than that of a mobile phone, and the patent licensing fee that can be collected will also be much higher than that of a mobile phone.

Executives chatted privately after the board meeting:

"The patent licensing fee for brain-computer connection to mobile phone is two hundred, so it's not too much to charge two thousand for the patent licensing of super battery."

“Two thousand? That’s too small. Do you know how much compensation CATL asked the other party to pay in the patent lawsuit?”

"How many?"

"Twenty-four percent of the total profit on the product, multiplied by ten percent."

"It's equivalent to 2.4 percent of the total profit, which isn't very high."

"The problem is that this manufacturer's products only infringed a small part of CATL's patents, and they did not use CATL's patents from beginning to end. They have to pay nearly 100 million yuan in compensation."

"Our patents cannot be stolen even if others want to."

"Who said that? Didn't the Indians steal endorphins? I said that the patent should not be granted to foreign pharmaceutical companies. The data from this year's semi-annual report shows that more than 20% of the world's endorphins come from the Indians."

"The problem is that India won't pay the patent licensing fee, and the Indian court won't accept your lawsuit."

I am so tired. I got a booster shot today and I felt so sleepy after it.

This year's stock return rate has exceeded 10%, and the Crow Select portfolio is still good. I am a conservative player.


(End of this chapter)